Zoetis (ZTS) reached $116.65 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.

Top-notch companies don't often come cheap. Zoetis (NYSE: ZTS) is one of the world's leading animal healthcare companies. The ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Zoetis Inc. recently presented at the World Vaccine Congress Washington 2026 at the Walter E. Washington Convention Center, where Senior VP of Global Biologics R&D Mahesh Kumar highlighted the company ...

Is ZTS a good stock to buy? We came across a bullish thesis on Zoetis Inc. on Quality At A Fair Price’s Substack. In this ...

(Reuters) - Top animal health company Zoetis Inc (ZTS.N) will buy Abaxis Inc (ABAX.O) for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics ...

Zoetis has upgraded its Vetscan OptiCell haematology analyser to include two new parameters—cellular haemoglobin concentration mean (CHCM) and plateletcrit (PCT)—once only available in reference labs.

Zoetis's stock has slumped in 2024, partly due to recent safety concerns regarding the company's arthritis drugs. Despite these safety concerns, Zoetis grew total revenue by 10% compared to Q1 2023 ...

Parsippany-based Zoetis Inc. announced on Monday it entered into an agreement to acquire Platinum Performance, a privately held, nutrition-focused animal health company. Platinum’s premium nutritional ...

Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount Seramount (formerly Working Mother Media) recognized Zoetis for forward-thinking programs and benefits related to parental ...

With the U.S. stock market butting against record highs, valuations certainly deserve a closer look. One company that may survive such scrutiny is Zoetis (ZTS +0.45%). Zoetis specializes in making ...

Zoetis said it would buy Abaxis, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash. The deal will bolster the Animal health company's position in the fast-growing ...